Will the FDA approve VERVE-102?
Price history — Before 2035
Last 7 days of market YES price (blue) with the fair-price range (orange).
━ market YES▬ fair range
Market price
79¢
74¢
72¢
70¢
62¢
52¢
Kalshi • Volume: 567.1 contracts • Updated 4h agoCloses: 2035-01-01
Kalshi · Science and Technology
OU's Pick
YES · Before 2035
at 79¢
Price gap
Kalshi79¢
→OU's fair62¢
−17¢ overpriced · pays 1.3×
Confidence
Moderate
The FDA granted Fast Track designation and cleared the IND application for VERVE-102 in early 2025 which accelerates the development timeline for this gene editing therapy.
Wide edge+17¢
Not financial advice. For informational purposes only. Prediction markets involve risk of loss. AI may contain errors.